Array BioPharma Competitors and Similar CompaniesClear all
NIOX's competitors and similar companies include Durect.
 NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Cupertino, US HQ |
Employees | Employees 91 | Employees 902% increase |
Valuation ($) | Valuation ($) 340.9 m | Valuation ($) 45.3 m |
Financial | ||
Revenue (est.) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) $2m (FY, 2024) |
Cost of goods | Cost of goods £11.1m (FY, 2025) | Cost of goods $78k (FY, 2024) |
Gross profit | Gross profit £38.2m (FY, 2025) | Gross profit $2m (FY, 2024) |
Net income | Net income £7m (FY, 2025) | Net income ($8.3m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 122.8m | Total funding raised $ 20m |
For sources of this data, please see the company profile
View Company Profiles
Durect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View company